Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan E Dorman

Showing results (21-30 of 134) with videos related to

Pageof 14
Sort By:
Plos Medicine|July 25, 2024
Research on the treatment of rifampin-susceptible tuberculosis-Time for a new approachWilliam Burman, Oxana Rucsineanu, C Robert Horsburgh, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2008
Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testingDavid W Dowdy, Richard E Chaisson, Gary Maartens, et al.
Plos One|December 11, 2012
The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort studyColleen F Hanrahan, Susan E Dorman, Linda Erasmus, et al.
Respiratory Medicine|December 9, 2022
Inhaled nitric oxide for adults with pulmonary non-tuberculous mycobacterial infectionPatrick A Flume, Bryan A Garcia, Dulaney Wilson, et al.
Respiratory Medicine|March 25, 2025
Relationship between culture conversion and clinical outcomes in nontuberculous mycobacterial pulmonary disease: Narrative reviewKevin L Winthrop, Christina M Mingora, Cara D Varley, et al.
AIDS (London, England)|August 15, 2014
Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in UgandaMaunank Shah, David Dowdy, Moses Joloba, et al.
Journal of Clinical Microbiology|June 11, 2010
Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosisMaunank Shah, Neil A Martinson, Richard E Chaisson, et al.
Plos One|May 16, 2012
Programmatic impact of QuantiFERON-TB Gold In-Tube implementation on latent tuberculosis diagnosis and treatment in a public health clinicMaunank Shah, Danielle DiPietro, Adena Greenbaum, et al.
The Lancet. Global Health|June 28, 2025
Implications of progressive lung damage and post-tuberculosis sequelae for the health benefits of prompt tuberculosis treatment in high HIV prevalence settings: a mathematical modelling analysisMelike Hazal Can, Sedona Sweeney, Brian W Allwood, et al.
Clinical and Diagnostic Laboratory Immunology|January 13, 2004
Immunoglobulin A (IgA) and IgG immune responses against P-90 antigen for diagnosis of pulmonary tuberculosis and screening for Mycobacterium tuberculosis infectionMarcus B Conde, Philip Suffys, Jose Roberto Lapa E Silva, et al.
Pageof 14

Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
Plos Medicine|July 25, 2024
Research on the treatment of rifampin-susceptible tuberculosis-Time for a new approachWilliam Burman, Oxana Rucsineanu, C Robert Horsburgh, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2008
Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testingDavid W Dowdy, Richard E Chaisson, Gary Maartens, et al.
Plos One|December 11, 2012
The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort studyColleen F Hanrahan, Susan E Dorman, Linda Erasmus, et al.
Respiratory Medicine|December 9, 2022
Inhaled nitric oxide for adults with pulmonary non-tuberculous mycobacterial infectionPatrick A Flume, Bryan A Garcia, Dulaney Wilson, et al.
Respiratory Medicine|March 25, 2025
Relationship between culture conversion and clinical outcomes in nontuberculous mycobacterial pulmonary disease: Narrative reviewKevin L Winthrop, Christina M Mingora, Cara D Varley, et al.
AIDS (London, England)|August 15, 2014
Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in UgandaMaunank Shah, David Dowdy, Moses Joloba, et al.
Journal of Clinical Microbiology|June 11, 2010
Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosisMaunank Shah, Neil A Martinson, Richard E Chaisson, et al.
Plos One|May 16, 2012
Programmatic impact of QuantiFERON-TB Gold In-Tube implementation on latent tuberculosis diagnosis and treatment in a public health clinicMaunank Shah, Danielle DiPietro, Adena Greenbaum, et al.
The Lancet. Global Health|June 28, 2025
Implications of progressive lung damage and post-tuberculosis sequelae for the health benefits of prompt tuberculosis treatment in high HIV prevalence settings: a mathematical modelling analysisMelike Hazal Can, Sedona Sweeney, Brian W Allwood, et al.
Clinical and Diagnostic Laboratory Immunology|January 13, 2004
Immunoglobulin A (IgA) and IgG immune responses against P-90 antigen for diagnosis of pulmonary tuberculosis and screening for Mycobacterium tuberculosis infectionMarcus B Conde, Philip Suffys, Jose Roberto Lapa E Silva, et al.
Pageof 14